Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • schelhorn
    Member
    • Sep 2010
    • 10

    Offering a user-paid NGS analysis pipeline in the cloud

    Dear Community,

    our lab has developed a NGS analysis pipeline for viral sequence analysis (both genomic resequencing and RNA-Seq, including some novel pathogen detection and viral quasi-species reconstruction approaches) that fulfills various analytical needs of our clinical cooperation partners. Since we believe that the pipeline might be of interest to the broader virological community we decided to integrate our workflow into Galaxy as a set of plugins.

    However, we do need our in-house computational capacities for our own analyses and are targeting people who do not have time and experience to set up their own Galaxy installation (for example, clinical virologists). Therefore we would like to provide the finished product as a non-profit service in the cloud (for example, by using Amazon AWS, for which the Galaxy installation is pretty straightforward).

    We envision (or at least, hope) that the pipeline will be used heavily and would therefore like to transfer the costs for the used resources to the user (e.g., the clinical virologist) in a pay-as-you-go manner. Amazon offers its 'DevPay' service for these purpose, basically an infrastructure to bill users of an AWS application instead of the application provider. Again, we do not want to make any profit with this service, we just want people to pay for the cpu cycles they burn with as few hassles for us as possible.

    I could well imagine that other academic institutions have similar goals, e.g. being willing to offer their work for free without wanting to cover the costs for analysis resources. Does anyone have experience with similar kinds of setups and would like to offer advice? I am looking for hints about technical (e.g. how to best integrate a Cloud Galaxy with DevPay or similar) as well as legal hurdles that we might have to be careful about (e.g., are we in conflict with open-source software licenses if billing is involved, even if we do not make a profit etc.).

    Thanks a bunch!

    Sven
    Last edited by schelhorn; 08-25-2011, 02:08 AM.

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Working...